AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Sumitomo Pharma Co., Ltd.
  3. Financials
  4. Revenue growth (%)

Sumitomo Pharma Co., Ltd.【JP:4506】

Market cap
¥1T
P/E ratio
10.9x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Mar 31, 202526.8-161.76%
Mar 31, 2024-43.4+5322.50%
Mar 31, 2023-0.8-109.37%
Mar 31, 20228.5+24.13%
Mar 31, 20216.9+34.64%
Mar 31, 20205.1-230.69%
Mar 31, 2019-3.9-124.27%
Mar 31, 201816.1+670.81%
Mar 31, 20172.1-75.61%
Mar 31, 20168.6-303.56%
Mar 31, 2015-4.2-136.64%
Mar 31, 201411.5-1611.84%
Mar 31, 2013-0.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)